Eads, TN, United States of America

Thomas Gary Bird

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Veru Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Thomas Gary Bird. Retrieved from https://idiyas.com/inventor/thomas-gary-bird

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Thomas Gary Bird

Introduction

Thomas Gary Bird is an accomplished inventor based in Eads, Tennessee. He holds a patent that showcases his contributions to the field of pharmaceuticals. His work focuses on the development of polymorphs that have significant applications in medical compositions.

Latest Patents

Thomas Gary Bird's notable patent is for "Polymorphs of [2-(1H-indol-3-yl)-1H-imidazol-4-yl](3,4,5-trimethoxyphenyl)methanone and its salts." This invention encompasses various polymorphs characterized by their x-ray diffraction patterns and DSC thermograms. These polymorphs are essential in the preparation of pharmaceutical compositions and products, highlighting their importance in the medical field.

Career Highlights

Bird is associated with Veru Inc., where he applies his expertise in pharmaceutical innovations. His work has contributed to advancements in drug formulation and delivery, making a significant impact on healthcare.

Collaborations

Throughout his career, Thomas Gary Bird has collaborated with notable colleagues, including Kester Gary Barnette and Mitchell S. Steiner. These partnerships have fostered a collaborative environment that enhances innovation and research.

Conclusion

Thomas Gary Bird's contributions to the field of pharmaceuticals through his patented innovations demonstrate his commitment to advancing medical science. His work continues to influence the development of effective pharmaceutical products.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…